Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 806

Dolomite

Intended Use: For use as a substitute for calcium and magnesium salts to enhance the mineral content of purified bottled water beverage at a level to provide a concentration of 40 mg/L calcium ions and 25 mg/L magnesium ions.
Basis: Scientific procedures
Notifier: Hogan Lovells US LLP
Notifier Address: 555 Thirteenth Street, NW
Washington, DC, 20004
GRAS Notice (releasable information): GRN 806 (in PDF) (747 KB)
Date of closure: May 17, 2019
FDA's Letter: FDA has no questions (in PDF) (276 kB)
-
-